“…Various immunosuppressive agents have been used in the treatment of patients with IMN, including chlorambucil, cyclophosphamide, azathioprine, cyclosporine (CsA), mycophenolate mofetil (MMF), tacrolimus, corticotropin, and, most recently, the anti-CD20 monoclonal antibody rituximab and the anti-C5a monoclonal antibody eculizumab. 3,8,9,14,15,[56][57][58][59][60][61]63,64,66,67,69,[72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89] Relevant data from the most important studies are listed in Tables 3 and 4. There are no randomized trials that compared the various classes of agents. It therefore is difficult to draw hard conclusions.…”